Prot #PS0007: Multicenter, Randomized, Parallel-group, Double-blind, Placebo-controlled (12-17 Years) Including a Single Open Label Arm (6-11 Years) Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol (CZP) in Pediatric Stud

Project: Research project

Project Details

StatusActive
Effective start/end date10/9/19 → 8/31/25

Funding

  • Parexel (Prot #PS0007)
  • UCB Biopharma SPRL (Prot #PS0007)